<DOC>
	<DOCNO>NCT01251952</DOCNO>
	<brief_summary>The primary goal study determine feasibility safety give two dos denileukin diftitox ( DD ) day 0 21 post autologous stem cell transplantation dose escalation fashion . Secondary goal include evaluate effect DD number percentage T-regs peripheral blood post transplant dose level , effect DD T cell ( CD4/CD8 ) reconstitution post transplant dose level determine time engraftment : absolute neutrophil count ( &gt; 0.5 x 10^9/L 3 consecutive day ) , platelet ( &gt; 20X 10^9/L 3 consecutive day ) . The hypothesis study base ability DD deplete T-regs subsequently enhance immune reconstitution reverse post transplant lymphopenia . This may indirectly enhance efficacy autologous transplantation reduce disease relapse .</brief_summary>
	<brief_title>Dose Escalation Trial Denileukin Diftitox ( Ontak ) Post Autologous Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Denileukin diftitox</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>All patient age &gt; =18 diagnose Multiple Myeloma schedule autologous peripheral blood hematopoietic stem cell transplant ( AHSCT ) screen eligibility . Patients must fulfill follow inclusion criterion eligible study : 1 . Diagnosis Multiple Myeloma 2 . Age &gt; =18 70 year . 3 . Able understand sign consent form . 4 . Can collect peripheral blood stem cell CD34+ cell dose least 5.0 x 106/kg . The CD34 molecule Cluster Differentiation molecule present hematopoietic stem cell . 5 . Conditioning regimen high dose Melphalan dose 200mg/m2 . 6 . Karnofsky Performance Score ( KPS ) &gt; 60 ECOG ( Eastern Cooperative Oncology Group ) performance status &lt; =2 7 . Kidney function : Creatinine &lt; 2.0 mg/dl creatinine clearance &gt; 50 ml/min 8 . Heart function : Ejection fraction &gt; 45 % 9 . Liver function test : Serum bilirubin , alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) less 3 X upper limit normal 10 . Lung function test : Forced Vital Capacity ( FVC ) , Forced Expiratory Volume One Second ( FEV1 ) Diffusing Capacity Lung Carbon Monoxide ( DLCO ) &gt; 45 % predict 1 . Age &lt; 18 year &gt; 70 year 2 . Previous exposure denileukin diftitox . 3 . Patients document uncontrolled central nervous system ( CNS ) disease . 4 . Previous AHSCT . 5 . Significant organ dysfunction deem inappropriate autologous transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>